Sign In
Buy MGTX
$12.52
+0.310 (+2.54%)
At Close: Jul 21, 2026
MeiraGTx to Host Parkinson’s Disease R&D Day in New York
09:30pm, Thursday, 05'th Dec 2019
LONDON and NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (MGTX), a vertically integrated, clinical stage gene therapy company, today announced it will host a Parkinson’s di
Gene Therapy the Next Best Thing: Here's Why (Revised)
08:49am, Thursday, 05'th Dec 2019
Recent activities like mergers and collaboration have boosted the gene therapy space this year, the broad and intriguing pipelines shows that the segment is poised to grow.
Gene Therapy the Next Best Thing: Here's Why
02:42pm, Wednesday, 04'th Dec 2019
Recent activities like mergers and collaboration have boosted the gene therapy space this year, the broad and intriguing pipelines shows that the segment is poised to grow.
MeiraGTx to Present at Upcoming Healthcare Conferences
09:30pm, Tuesday, 26'th Nov 2019
LONDON and NEW YORK, Nov. 26, 2019 -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced.
Can You Imagine How MeiraGTx Holdings's (NASDAQ:MGTX) Shareholders Feel About The 21% Share Price Increase?
02:13pm, Wednesday, 13'th Nov 2019
It hasn't been the best quarter for MeiraGTx Holdings plc (NASDAQ:MGTX) shareholders, since the share price has fallen...
MeiraGTx Reports Third Quarter 2019 Financial Results
01:00pm, Thursday, 07'th Nov 2019
LONDON and NEW YORK, Nov. 07, 2019 -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial.
Is MeiraGTx Holdings plc (MGTX) Going to Burn These Hedge Funds?
08:13pm, Monday, 28'th Oct 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and thes
MeiraGTx to Present at Upcoming Scientific and Investor Conferences
08:45pm, Thursday, 03'rd Oct 2019
LONDON and NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that the Company will present
MeiraGTx To Present Clinical Data from Phase 1/2 Trial of AAV-RPE65 at Upcoming Scientific Conferences
12:30pm, Tuesday, 10'th Sep 2019
MeiraGTx Holdings plc (MGTX), a vertically integrated, clinical stage gene therapy company, today announced that clinical data updates from the Company’s Phase 1/2 trial of AAV-RPE65 will be presen
Could MeiraGTx Holdings plc's (NASDAQ:MGTX) Investor Composition Influence The Stock Price?
04:17pm, Thursday, 15'th Aug 2019
Every investor in MeiraGTx Holdings plc (NASDAQ:MGTX) should be aware of the most powerful shareholder groups...
